Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Typing01:10

Blood Typing

3.6K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic Confirmation of HLA-B*15:591 by Next Generation Sequencing.

HLA·2026
Same author

Genomic Confirmation of HLA-C*01:155, by Next Generation Sequencing.

HLA·2026
Same author

Characterisation of the Novel HLA-A*26:268 Allele by Next Generation Sequencing.

HLA·2026
Same author

Genomic Confirmation of HLA-DQA1*01:169, by Next Generation Sequencing.

HLA·2026
Same author

Blood bags under scrutiny: The dark spot investigation.

Transfusion·2026
Same author

Characterisation of the Novel HLA-DPA1*03:25 Allele by Next Generation Sequencing.

HLA·2026

Related Experiment Video

Updated: Mar 21, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.7K

Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians.

Carrie A Schinstock1, Manish J Gandhi, Mark D Stegall

  • 11 William J. von Liebig Transplant Center, Mayo Clinic, Rochester, MN.2 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.

Transplantation
|May 4, 2016
PubMed
Summary
This summary is machine-generated.

Interpreting alloantibody test results in transplantation can be complex. This review offers a practical guide for transplant physicians to improve clinical decision-making regarding antibody data and enhance patient management.

More Related Videos

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

1.0K
Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

137.8K

Related Experiment Videos

Last Updated: Mar 21, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

10.7K
Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

1.0K
Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

137.8K

Area of Science:

  • Immunology
  • Transplantation Science
  • Clinical Diagnostics

Background:

  • Sensitive alloantibody detection methods are crucial in clinical transplantation.
  • Complexity of solid phase and crossmatch assay data can cause confusion in clinical decision-making.

Purpose of the Study:

  • To provide a practical guide for transplant physicians on interpreting alloantibody data.
  • To supplement consultation with local tissue typing experts.
  • To enhance clinical management in transplantation.

Main Methods:

  • Review of sources of variability in solid phase and crossmatch assays.
  • Discussion of recent data on C1q binding antibodies and IgG subclass testing.

Main Results:

  • Identified sources of variability in antibody detection assays.
  • Summarized recent advancements in understanding C1q binding antibodies and IgG subclasses.

Conclusions:

  • A pragmatic approach to alloantibody testing interpretation is outlined.
  • The guide aims to enhance clinical management despite current knowledge limitations.